(Q43901112)

English

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction

scientific article published in November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction (English)

1 reference

Europe PubMed Central

27 November 2017

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

27 November 2017

author name string

Stentoft J

1

1 reference

Europe PubMed Central

27 November 2017

Pallisgaard N

2

1 reference

Europe PubMed Central

27 November 2017

Kjeldsen E

3

1 reference

Europe PubMed Central

27 November 2017

Holm MS

4

1 reference

Europe PubMed Central

27 November 2017

Nielsen JL

5

1 reference

Europe PubMed Central

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2001

1 reference

Europe PubMed Central

27 November 2017

European Journal of Haematology

1 reference

Europe PubMed Central

27 November 2017

67

1 reference

Europe PubMed Central

27 November 2017

302-308

1 reference

Europe PubMed Central

27 November 2017

5-6

1 reference

Europe PubMed Central

27 November 2017

The biology of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00556.X

21 January 2018

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00556.X

21 January 2018

Acute leukaemia in bcr/abl transgenic mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00556.X

21 January 2018

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00556.X

21 January 2018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00556.X

21 January 2018

Detection and quantification of residual disease in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00556.X

21 January 2018

A novel method for real time quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00556.X

21 January 2018

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00556.X

21 January 2018

Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00556.X

21 January 2018

Identifiers

10.1034/J.1600-0609.2001.00556.X

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43901112&oldid=2104260260"